Can Tramadol Cause Seizures?
Yes, tramadol can definitively cause seizures, even at recommended therapeutic doses, and this risk increases significantly with higher doses, concomitant use of certain medications, and in specific patient populations.
Seizure Risk Profile
The FDA drug label explicitly warns that seizures have been reported in patients receiving tramadol within the recommended dosage range, with spontaneous post-marketing reports indicating increased seizure risk at doses above the recommended range 1. This represents the highest level of regulatory concern and should guide clinical decision-making.
Dose-Dependent Risk
Lower doses are specifically recommended for adults aged ≥75 years and those with hepatic and/or renal dysfunction to reduce the risk of seizures 2. The NCCN guidelines (2025) recommend:
- Maximum daily dose of 400 mg for immediate-release formulations (100 mg 4 times daily)
- Maximum of 300 mg/day for extended-release formulations
- Reduced doses in elderly and organ dysfunction patients 2
Recent research demonstrates concerning seizure rates:
- 38% seizure rate in tramadol poisoning cases 3
- 3% seizure rate at therapeutic doses 3
- 37% seizure rate in tramadol abusers 3
- In a 2025 Danish study, tramadol-induced seizures accounted for 17.7% of all seizure admissions in young adults (15-30 years) to the emergency department 4
High-Risk Populations and Situations
Medication Interactions That Increase Seizure Risk
The FDA label and NCCN guidelines identify specific drug combinations that significantly increase seizure risk 1, 2:
Concomitant use that INCREASES seizure risk:
- SSRIs (selective serotonin reuptake inhibitors)
- SNRIs (serotonin-norepinephrine reuptake inhibitors)
- Tricyclic antidepressants (TCAs)
- MAO inhibitors
- Other opioids
- Neuroleptics
- Other drugs that reduce seizure threshold
Patient-Specific Risk Factors
Risk of convulsions increases in patients with 1:
- Epilepsy
- History of seizures
- Head trauma
- Metabolic disorders
- Alcohol and drug withdrawal
- CNS infections
Demographic Risk Factors
Recent research identifies Asian patients as having significantly higher seizure risk (OR = 7.2,95% CI: 1.9-27.3) 5. Additionally, patients abusing or misusing tramadol have 3.2 times higher odds of seizures (OR = 3.2,95% CI: 1.2-8.3) 5.
Clinical Implications
Rapid Onset
A 2025 case report documented seizures occurring within 4 minutes of IV tramadol 150 mg administration, despite rigorous screening for seizure risk 6. This led to termination of the 150 mg treatment arm in the study, with investigators noting that even 100 mg may provide insufficient safety margin.
Naloxone Considerations
Critical caveat: In tramadol overdose, naloxone administration may increase the risk of seizure 1. This is explicitly stated in the FDA warning and should guide overdose management. However, research data on this association remains mixed, with one study finding no significant association (OR = 0.47,95% CI: 0.15-1.49) 3, while another found no significant association (OR = 0.30,95% CI 0.07-1.25) 5.
Prescribing Recommendations
The ACEP guidelines (2024) specifically note that prescribed tramadol can lower the seizure threshold 7, reinforcing that this is a recognized clinical concern in emergency medicine practice.
Given the evidence:
- Avoid tramadol in patients taking serotonergic medications 2
- Use caution or avoid in patients with seizure history or risk factors 1
- Consider alternative analgesics in high-risk populations 2
- Educate patients about seizure risk, particularly when exceeding recommended doses 1
Contradictory Evidence
One 2022 Korean nationwide study found no significant association between tramadol use and seizures (aOR 0.94,95% CI 0.98-1.43) 8, and a 2019 US study using broad seizure definitions found no association (OR 1.03,95% CI 0.93-1.15) 9. However, when the latter study used a more specific definition restricted to hospital visits with principal seizure diagnosis, the association became statistically significant (OR 1.41,95% CI 1.11-1.79) 9. This suggests that tramadol-related seizures may be more severe, requiring hospitalization.
The preponderance of evidence, particularly FDA labeling, NCCN guidelines, and multiple research studies, supports that tramadol carries genuine seizure risk that increases with dose and specific patient/medication factors.